Cardiomyocytes derived from human embryonic stem cells (hESC-CMs) are regarded as promising cell source for regenerative medicine, drug testing and disease modeling. Nevertheless, these cardiomyocytes are immature in terms of contractile structure, metabolism and electrophysiological properties. There are increasing efforts using biological, chemical and physical approaches to facilitate maturation of hESC-CMs, with 3D matrix recognized as an optimal in vitro platform. In light of the previous findings, cardiac tissue strips were fabricated by encapsulating hESC-CMs into collagen/matrigel matrix in current study. The engineered tissue strips contract against mounted ends and grow into compact tissues with spontaneous beating. We hypothesize...
Human induced pluripotent stem cells (hiPSCs) are a robust source for cardiac regenerative therapy d...
Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) are widely suggested as a suit...
BACKGROUND:Delivery of stem cells to the failing heart is a promising therapeutic strategy. However,...
Congress Theme: Past, Present, Future: the evolution of Regenerative MedicinePoster abstractsRegene...
Thesis (Ph.D.)--University of Washington, 2014Cardiac tissue engineering enables the generation of f...
Cardiac tissue engineering is a strategy to replace damaged contractile tissue and model cardiac dis...
Heart disease is the leading cause of death in many developing and industrialized countries. The los...
Heart disease is the leading cause of death in many developing and industrialized countries. The los...
Myocardial infarction (MI) prompts a substantial loss of cardiomyocytes (CM) in the human heart, an ...
Engineered cardiac tissue models become increasingly important for understanding normal and diseased...
Thesis (Master's)--University of Washington, 2015Cardiac tissue engineering is a promising approach ...
Cardiovascular diseases are a major cause of mortality resulting in serious health concerns and dete...
While cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) represent a promising popu...
There is currently an overwhelming need for functional replacement of diseased or damaged cardiac ti...
Author ManuscriptThe application of tissue-engineering approaches to human induced pluripotent stem ...
Human induced pluripotent stem cells (hiPSCs) are a robust source for cardiac regenerative therapy d...
Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) are widely suggested as a suit...
BACKGROUND:Delivery of stem cells to the failing heart is a promising therapeutic strategy. However,...
Congress Theme: Past, Present, Future: the evolution of Regenerative MedicinePoster abstractsRegene...
Thesis (Ph.D.)--University of Washington, 2014Cardiac tissue engineering enables the generation of f...
Cardiac tissue engineering is a strategy to replace damaged contractile tissue and model cardiac dis...
Heart disease is the leading cause of death in many developing and industrialized countries. The los...
Heart disease is the leading cause of death in many developing and industrialized countries. The los...
Myocardial infarction (MI) prompts a substantial loss of cardiomyocytes (CM) in the human heart, an ...
Engineered cardiac tissue models become increasingly important for understanding normal and diseased...
Thesis (Master's)--University of Washington, 2015Cardiac tissue engineering is a promising approach ...
Cardiovascular diseases are a major cause of mortality resulting in serious health concerns and dete...
While cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) represent a promising popu...
There is currently an overwhelming need for functional replacement of diseased or damaged cardiac ti...
Author ManuscriptThe application of tissue-engineering approaches to human induced pluripotent stem ...
Human induced pluripotent stem cells (hiPSCs) are a robust source for cardiac regenerative therapy d...
Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) are widely suggested as a suit...
BACKGROUND:Delivery of stem cells to the failing heart is a promising therapeutic strategy. However,...